A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment
about
Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysisEffectiveness and safety of monoclonal antibodies for metastatic colorectal cancer treatment: systematic review and meta-analysisAngiogenesis inhibitor bevacizumab increases the risk of ischemic heart disease associated with chemotherapy: a meta-analysisTreatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature.Ziv-aflibercept in metastatic colorectal cancerRandomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study.Monoclonal antibodies in gastrointestinal cancers.Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer.Circulating tumor cells: what we know, what do we want to know about them and are they ready to be used in clinics?Systemic treatment of liver metastases from colorectal cancer.The clinical risk score predicts the effectiveness of adjuvant chemotherapy for colorectal liver metastasis.
P2860
Q26774704-077C7A2C-156C-4C97-A7B3-089C1C541D11Q26777704-BF84B6C7-0A92-4636-8F31-982EF5CF8EFFQ28534015-CCE477A1-AB3D-49F2-97A8-DBAEF135B283Q34294365-F1637BA2-B9E2-480D-BF20-95FD817AF20AQ34658579-8672F126-ECA6-48E9-8233-BF1A5F5B1F92Q37587441-F2B4898D-D750-4608-A97B-384B61699A5EQ38084684-2DDA5ECB-FD46-442D-8CB4-E5156CEBFAB8Q38626963-81FFA773-8E5C-4471-B3F5-686A2F622AE3Q38697494-BC1935A3-7197-40BA-887C-DA5DF74DD81EQ39949794-95E5BBB8-1FF1-4460-BE7C-910838D989A8Q53618470-397ABAC4-2150-4525-9ED2-79BAC2A9BB46
P2860
A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A randomized two arm phase III ...... OX alone as adjuvant treatment
@ast
A randomized two arm phase III ...... OX alone as adjuvant treatment
@en
type
label
A randomized two arm phase III ...... OX alone as adjuvant treatment
@ast
A randomized two arm phase III ...... OX alone as adjuvant treatment
@en
prefLabel
A randomized two arm phase III ...... OX alone as adjuvant treatment
@ast
A randomized two arm phase III ...... OX alone as adjuvant treatment
@en
P2093
P2860
P356
P1433
P1476
A randomized two arm phase III ...... OX alone as adjuvant treatment
@en
P2093
Andre M Bergman
Emile E Voest
Henk M Verheul
Inne H M Borel Rinkes
Joost R M van der Sijp
Nikol Snoeren
Otilia Dalesio
R van Hillegersberg
Rob A E M Tollenaar
Sander B Schouten
P2860
P2888
P356
10.1186/1471-2407-10-545
P407
P577
2010-10-11T00:00:00Z
P5875
P6179
1021313491